Soru

Zorluk: OrtaSubstance-Related and Addictive Disorders

Emergency medical services arrive at the hospital with an unresponsive individual found in a public transit station. Initial assessment reveals a respiratory rate of 4 breaths per minute, oxygen saturation of 82% on room air, and miotic pupils. Track marks are visible on the patient's antecubital fossae. The clinical team must manage the patient from acute presentation through stabilization and eventual hospital discharge. Arrange the following management steps in the most appropriate chronological sequence for this patient.

  1. 1Administer intravenous naloxone to reverse acute respiratory depression.
  2. 2Monitor the patient in the emergency department for recurrent sedation and hypoventilation.
  3. 3Observe the patient until mild-to-moderate objective opioid withdrawal symptoms emerge.
  4. 4Initiate maintenance pharmacotherapy with sublingual buprenorphine.
  5. 5Provide a take-home naloxone prescription and link to outpatient psychosocial support.

Cevap

The correct sequence prioritizes immediate respiratory resuscitation with naloxone, followed by observation for recurrent sedation, waiting for the onset of withdrawal symptoms, inducing buprenorphine therapy, and finally providing a take-home naloxone kit upon discharge.
The clinical sequence must follow the physiological realities of opioid overdose and pharmacotherapy. Life-saving ventilation restoration via naloxone is step one. Because naloxone wears off in 30-90 minutes, observation is step two. To transition to long-term buprenorphine, the patient must be in withdrawal to avoid precipitated withdrawal (step three and four). Finally, harm reduction (take-home naloxone) completes the hospital course (step five).

Adım Adım Çözüm

1
Address the immediate life-threatening emergency.
Intravenous naloxone reverses the opioid-induced respiratory depression.
The patient's respiratory rate is critically low (4/min) with hypoxia, requiring immediate intervention to prevent anoxic brain injury or cardiac arrest.
2
Ensure sustained respiratory stability.
The patient is monitored for recurrent sedation.
Naloxone's short half-life creates a high risk for the patient to slip back into respiratory depression if the ingested opioid outlasts the antagonist.
3
Prepare for medication-assisted treatment induction.
The clinical team waits for mild-to-moderate withdrawal symptoms.
Administering buprenorphine while full agonists are still bound to receptors will cause severe precipitated withdrawal.
4
Manage opioid use disorder chronically.
Sublingual buprenorphine is administered.
Buprenorphine relieves withdrawal, controls cravings, and stabilizes the patient for long-term recovery.
5
Execute safe discharge planning.
Take-home naloxone and counseling referrals are provided.
Harm reduction strategies must be implemented prior to returning the patient to the community to mitigate future overdose risks.

Anahtar Kavram

Management of opioid use disorder requires a sequential approach: acute resuscitation with an antagonist (naloxone), observation due to pharmacokinetic mismatches, proper timing of partial agonist induction (buprenorphine) to avoid precipitated withdrawal, and harm reduction at discharge.
Bu soruyu puanla